ICL Group Earnings Calls
| Release date | May 13, 2026 |
| EPS estimate | $0.100 |
| EPS actual | $0.110 |
| EPS Surprise | 10.00% |
| Revenue estimate | 1.924B |
| Revenue actual | 2.023B |
| Revenue Surprise | 5.17% |
| Release date | Feb 18, 2026 |
| EPS estimate | $0.0900 |
| EPS actual | $0.0900 |
| Revenue estimate | 1.77B |
| Revenue actual | 1.701B |
| Revenue Surprise | -3.88% |
| Release date | Nov 12, 2025 |
| EPS estimate | $0.0900 |
| EPS actual | $0.100 |
| EPS Surprise | 11.11% |
| Revenue estimate | 1.949B |
| Revenue actual | 1.853B |
| Revenue Surprise | -4.91% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0900 |
| EPS Surprise | 12.50% |
| Revenue estimate | 1.832B |
| Revenue actual | 1.832B |
Last 4 Quarters for ICL Group
Below you can see how ICL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $5.99 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0900 |
| EPS surprise | 12.50% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $6.27 |
| Aug 01, 2025 | $6.16 |
| Aug 04, 2025 | $6.02 |
| Aug 05, 2025 | $6.03 |
| Aug 06, 2025 | $5.99 |
| Aug 07, 2025 | $6.20 |
| Aug 08, 2025 | $6.19 |
| Aug 11, 2025 | $6.02 |
| Aug 12, 2025 | $5.93 |
| 4 days before | -4.47% |
| 4 days after | -1.00% |
| On release day | 3.51% |
| Change in period | -5.42% |
| Release date | Nov 12, 2025 |
| Price on release | $5.50 |
| EPS estimate | $0.0900 |
| EPS actual | $0.100 |
| EPS surprise | 11.11% |
| Date | Price |
|---|---|
| Nov 06, 2025 | $5.51 |
| Nov 07, 2025 | $5.64 |
| Nov 10, 2025 | $5.70 |
| Nov 11, 2025 | $5.66 |
| Nov 12, 2025 | $5.50 |
| Nov 13, 2025 | $5.49 |
| Nov 14, 2025 | $5.46 |
| Nov 17, 2025 | $5.41 |
| Nov 18, 2025 | $5.39 |
| 4 days before | -0.181% |
| 4 days after | -2.00% |
| On release day | -0.182% |
| Change in period | -2.18% |
| Release date | Feb 18, 2026 |
| Price on release | $5.50 |
| EPS estimate | $0.0900 |
| EPS actual | $0.0900 |
| Date | Price |
|---|---|
| Feb 11, 2026 | $5.75 |
| Feb 12, 2026 | $5.73 |
| Feb 13, 2026 | $5.73 |
| Feb 17, 2026 | $5.78 |
| Feb 18, 2026 | $5.50 |
| Feb 19, 2026 | $5.39 |
| Feb 20, 2026 | $5.43 |
| Feb 23, 2026 | $5.28 |
| Feb 24, 2026 | $5.19 |
| 4 days before | -4.35% |
| 4 days after | -5.64% |
| On release day | -2.00% |
| Change in period | -9.74% |
| Release date | May 13, 2026 |
| Price on release | $6.80 |
| EPS estimate | $0.100 |
| EPS actual | $0.110 |
| EPS surprise | 10.00% |
| Date | Price |
|---|---|
| May 07, 2026 | $6.00 |
| May 08, 2026 | $6.37 |
| May 11, 2026 | $6.50 |
| May 12, 2026 | $6.38 |
| May 13, 2026 | $6.80 |
| May 14, 2026 | $6.57 |
| May 15, 2026 | $6.41 |
| May 18, 2026 | $6.42 |
| May 19, 2026 | $6.49 |
| 4 days before | 13.33% |
| 4 days after | -4.63% |
| On release day | -3.46% |
| Change in period | 8.08% |
ICL Group Earnings Call Transcript Summary of Q1 2026
ICL reported a strong start to 2026 with Q1 sales of $2.0 billion (up 14% y/y), adjusted net income of $139 million (adjusted EPS $0.11), and consolidated adjusted EBITDA of $412 million (up 15%). All four business segments contributed to growth: Potash sales rose ~25% y/y with average potash price of $362/ton and higher production volumes; Phosphate Solutions sales increased 18% but were pressured by sharply higher sulfur costs; Industrial Products benefited from stronger bromine pricing; Growing Solutions saw an 11% sales increase driven by China, India and price/volume improvements. Management raised 2026 EBITDA guidance by $100 million to a range of $1.5–$1.7 billion, expects potash volumes of 4.5–4.7 million tons, and an adjusted tax rate of ~30%. Operating cash flow was $195 million, free cash flow $61 million, available liquidity $1.5 billion, net debt/EBITDA ~1.5x, and the company will continue a 50% adjusted-net-income payout policy (Q1 dividend $69 million, trailing 12-month yield 3.7%). Key risks noted: stronger shekel versus dollar (currency headwind for Israeli operations), materially higher raw material costs—especially sulfur—and uncertainty tied to the Middle East conflict (which affects supply, prices and logistics). Management emphasized operational resilience, productivity initiatives, continued specialty growth (including a ~50% acquisition of Bartek and a new specialty fertilizer facility in India), and close monitoring/mitigation of input-cost and FX pressures.
Sign In
Buy ICL